{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T18:28:29Z","timestamp":1791052109500,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T00:00:00Z","timestamp":1656028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T00:00:00Z","timestamp":1656028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Vessels"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s00380-022-02114-y","type":"journal-article","created":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T02:02:31Z","timestamp":1656036151000},"page":"2128-2136","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["The effects of biologic agents on cardiovascular risk factors and atherosclerosis in rheumatoid arthritis patients: a prospective observational study"],"prefix":"10.1007","volume":"37","author":[{"given":"G. V.","family":"Papamichail","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. E.","family":"Markatseli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. N.","family":"Georgiadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. G.","family":"Xydis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Milionis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. A.","family":"Drosos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. V.","family":"Voulgari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,24]]},"reference":[{"issue":"10055","key":"2114_CR1","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","volume":"388","author":"JS Smolen","year":"2016","unstructured":"Smolen JS, Aletaha D, McInnes IB (2016) Rheumatoid arthritis. Lancet 388(10055):2023\u20132038","journal-title":"Lancet"},{"issue":"2","key":"2114_CR2","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.pop.2018.02.010","volume":"45","author":"EA Littlejohn","year":"2018","unstructured":"Littlejohn EA, Monrad S (2018) Early diagnosis and treatment of rheumatoid arthritis. Prim Care 45(2):237\u2013255","journal-title":"Prim Care"},{"issue":"2","key":"2114_CR3","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.rdc.2010.02.002","volume":"36","author":"MJ Kaplan","year":"2010","unstructured":"Kaplan MJ (2010) Cardiovascular complications of rheumatoid arthritis: assessment, prevention, and treatment. Rheum Dis Clin North Am 36(2):405\u2013426","journal-title":"Rheum Dis Clin North Am"},{"issue":"11","key":"2114_CR4","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1136\/ard.61.11.955","volume":"61","author":"N Goodson","year":"2002","unstructured":"Goodson N, Symmons D (2002) Rheumatoid arthritis in women: still associated with an increased mortality. Ann Rheum Dis 61(11):955\u2013956","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"2114_CR5","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1056\/NEJM199901143400207","volume":"340","author":"R Ross","year":"1999","unstructured":"Ross R (1999) Atherosclerosis\u2014an inflammatory disease. N Engl J Med 340(2):115\u2013126","journal-title":"N Engl J Med"},{"issue":"7347","key":"2114_CR6","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nature10146","volume":"473","author":"P Libby","year":"2011","unstructured":"Libby P, Ridker PM, Hansson GK (2011) Progress and challenges in translating the biology of atherosclerosis. Nature 473(7347):317\u2013325","journal-title":"Nature"},{"issue":"8","key":"2114_CR7","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00296-020-04616-2","volume":"40","author":"AI Venetsanopoulou","year":"2020","unstructured":"Venetsanopoulou AI, Pelechas E, Voulgari PV, Drosos AA (2020) The lipid paradox in rheumatoid arthritis: the dark horse of the augmented cardiovascular risk. Rheumatol Int 40(8):1181\u20131191","journal-title":"Rheumatol Int"},{"issue":"1070","key":"2114_CR8","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1136\/postgradmedj-2013-204715rep","volume":"90","author":"J Zhang","year":"2014","unstructured":"Zhang J, Chen L, Delzell E, Muntner P, Hillegass WB, Safford MM, Iris Yolanda I, Millan N, Curtis CCS Jr (2014) The association between inflammatory markers, serum lipids and the risk of cardiovascular events in patients with rheumatoid arthritis. Postgrad Med J 90(1070):722\u2013729","journal-title":"Postgrad Med J"},{"issue":"1","key":"2114_CR9","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13075-015-0559-8","volume":"17","author":"DY Chen","year":"2015","unstructured":"Chen DY, Chen YM, Hsieh TY, Hsieh CW, Lin CC, Lan JL (2015) Significant effects of biologic therapy on lipid profiles and insulin resistance in patients with rheumatoid arthritis. Arthritis Res Ther 17(1):52","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"2114_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0130709","volume":"10","author":"SA Provan","year":"2015","unstructured":"Provan SA, Berg IJ, Hammer HB, Mathiessen A, Kvien TK, Semb AG (2015) The impact of newer biological disease modifying anti-rheumatic drugs on cardiovascular risk factors: a 12-month longitudinal study in rheumatoid arthritis patients treated with rituximab, abatacept and tociliziumab. PLoS ONE 10(6):e0130709","journal-title":"PLoS ONE"},{"issue":"2","key":"2114_CR11","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3346\/jkms.2016.31.2.202","volume":"31","author":"DS Novikova","year":"2016","unstructured":"Novikova DS, Popkova TV, Lukina GV, Luchikhina EL, Karateev DE, Volkov AV, Novikov AA, Aleksandrova EN, Nasonov EL (2016) The effects of rituximab on lipids, arterial stiffness and carotid intima-media thickness in rheumatoid arthritis. J Korean Med Sci 31(2):202\u2013207","journal-title":"J Korean Med Sci"},{"issue":"10","key":"2114_CR12","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1136\/annrheumdis-2015-207872","volume":"75","author":"C Gabay","year":"2016","unstructured":"Gabay C, McInnes IB, Kavanaugh A, Tuckwell K, Klearman M, Pulley J, Sattar N (2016) Comparison of lipid and lipid-associated cardiovascular risk marker changes after treatment with tocilizumab or adalimumab in patients with rheumatoid arthritis. Ann Rheum Dis 75(10):1806\u20131812","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"2114_CR13","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, Combe B, Costenbader KH, Dougados M, Emery P, Ferraccioli G, Hazes JMW, Hobbs K, Huizinga TWJ, Kavanaugh A, Kay J, Kvien TK, Laing T, Mease P, M\u00e9nard HA, Moreland LW, Naden RL, Pincus T, Smolen JS, Stanislawska-Biernat E, Symmons D, Tak PP, Upchurch KS, Vencovsk\u00fd J, Wolfe F, Hawker G (2010) Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62(9):2569\u20132581","journal-title":"Arthritis Rheum"},{"issue":"1","key":"2114_CR14","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/art.1780380107","volume":"38","author":"ML Prevoo","year":"1995","unstructured":"Prevoo ML, van \u2019t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38(1):44\u201348","journal-title":"Arthritis Rheum"},{"issue":"9","key":"2114_CR15","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1136\/annrheumdis-2011-200726","volume":"71","author":"JA Avina-Zubieta","year":"2012","unstructured":"Avina-Zubieta JA, Thomas J, Sadatsafavi M, Lehman AJ, Lacaille D (2012) Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis 71(9):1524\u20131529","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"2114_CR16","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1136\/ard.2006.059980","volume":"67","author":"A Gonzalez","year":"2008","unstructured":"Gonzalez A, Maradit KH, Crowson CS, Ballman KV, Roger VL, Jacobsen SJ, O\u2019Fallon WM, Gabriel S (2008) Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients? Ann Rheum Dis 67(1):64\u201369","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"2114_CR17","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1097\/BOR.0b013e32834ff2fd","volume":"24","author":"SE Gabriel","year":"2012","unstructured":"Gabriel SE, Crowson CS (2012) Risk factors for cardiovascular disease in rheumatoid arthritis. Curr Opin Rheumatol 24(2):171\u2013176","journal-title":"Curr Opin Rheumatol"},{"issue":"7","key":"2114_CR18","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1136\/annrheumdis-2016-209744","volume":"76","author":"GJ Fent","year":"2017","unstructured":"Fent GJ, Greenwood JP, Plein S, Buch MH (2017) The role of non-invasive cardiovascular imaging in the assessment of cardiovascular risk in rheumatoid arthritis: where we are and where we need to be. Ann Rheum Dis 76(7):1169\u20131175","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"2114_CR19","first-page":"38","volume":"59","author":"M Carotti","year":"2007","unstructured":"Carotti M, Salaffi F, Mangiacotti M, Cerioni A, Giuseppetti G, Grassi W (2007) Atherosclerosis in rheumatoid arthtritis: the role of high-resolution B mode ultrasound in the measurement of the arterial intima-media thickness. Reumatismo 59(1):38\u201349","journal-title":"Reumatismo"},{"issue":"4","key":"2114_CR20","doi-asserted-by":"publisher","first-page":"730","DOI":"10.3899\/jrheum.090670","volume":"37","author":"H Kobayashi","year":"2010","unstructured":"Kobayashi H, Giles JT, Polak JF, Blumenthal RS, Leffell MS, Szklo M, Petri M, Gelber AC, Post W, Bathon JM (2010) Increased prevalence of carotid artery atherosclerosis in rheumatoid arthritis is artery-specific. J Rheumatol 37(4):730\u2013739","journal-title":"J Rheumatol"},{"issue":"1","key":"2114_CR21","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1089\/jwh.2008.0797","volume":"18","author":"LL Schott","year":"2009","unstructured":"Schott LL, Kao AH, Cunningham A, Wildman RP, Kuller LH, Sutton-Tyrrell K, Wasko MCM (2009) Do carotid artery diameters manifest early evidence of atherosclerosis in women with rheumatoid arthritis? J Womens Health 18(1):21\u201329","journal-title":"J Womens Health"},{"key":"2114_CR22","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.atherosclerosis.2020.01.011","volume":"295","author":"L Lind","year":"2020","unstructured":"Lind L, Gigante B, Borne Y, M\u00e4larstig A, Sundstr\u00f6m J, \u00c4rnl\u00f6v J, Ingelsson E, Baldassarre D, Tremoli E, Veglia F, Hamsten A, Orho-Melander M, Nilsson J, Melander O, Engstr\u00f6m G (2020) The plasma protein profile and cardiovascular risk differ between intima-media thickness of the common carotid artery and the bulb: a meta-analysis and a longitudinal evaluation. Atherosclerosis 295:25\u201330","journal-title":"Atherosclerosis"},{"issue":"7","key":"2114_CR23","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1007\/s10554-018-1319-z","volume":"34","author":"S Gregg","year":"2018","unstructured":"Gregg S, Li TY, Hetu M-F, Pang SC, Ewart P, Johri AM (2018) Relationship between carotid artery atherosclerosis and bulb geometry. Int J Cardiovasc Imaging 34(7):1081\u20131090","journal-title":"Int J Cardiovasc Imaging"},{"issue":"7","key":"2114_CR24","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1002\/art.11078","volume":"48","author":"I Del Rinc\u03c3n","year":"2003","unstructured":"Del Rinc\u03c3n I, Williams K, Stern MP, Freeman GL, O\u2019leary DH, Escalante A (2003) Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects. Arthritis Rheum 48(7):1833\u20131840","journal-title":"Arthritis Rheum"},{"key":"2114_CR25","doi-asserted-by":"publisher","first-page":"49","DOI":"10.2174\/1874312901610010049","volume":"10","author":"JE Pope","year":"2016","unstructured":"Pope JE, Nevskaya T, Barra L, Parraga G (2016) Carotid artery atherosclerosis in patients with active rheumatoid arthritis: predictors of plaque occurrence and progression over 24 weeks. Open Rheumatol J 10:49\u201359","journal-title":"Open Rheumatol J"},{"issue":"3","key":"2114_CR26","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ejr.2011.03.005","volume":"33","author":"E Kassem","year":"2011","unstructured":"Kassem E, Ghonimy R, Adel M, El-Sharnoby G (2011) Non traditional risk factors of carotid atherosclerosis in rheumatoid arthritis. Egypt Rheumatol 33(3):113\u2013119","journal-title":"Egypt Rheumatol"},{"issue":"6","key":"2114_CR27","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1136\/annrheumdis-2013-205058","volume":"74","author":"I Del Rincon","year":"2015","unstructured":"Del Rincon I, Polak JF, O\u2019Leary DH, Battafarano DF, Erikson JM, Restrepo JF, Molina E, Escalante A (2015) Systemic inflammation and cardiovascular risk factors predict rapid progression of atherosclerosis in rheumatoid arthritis. Ann Rheum Dis 74(6):1118\u20131123","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"2114_CR28","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.semarthrit.2007.09.008","volume":"38","author":"AN Georgiadis","year":"2008","unstructured":"Georgiadis AN, Voulgari PV, Argyropoulou MI (2008) Early treatment reduces the cardiovascular risk factors in newly diagnosed rheumatoid arthritis patients. Semin Arthritis Rheum 38(1):13\u201319","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"2114_CR29","doi-asserted-by":"publisher","first-page":"R82","DOI":"10.1186\/ar1952","volume":"8","author":"AN Georgiadis","year":"2006","unstructured":"Georgiadis AN, Papavasiliou EC, Lourida ES, Alamanos Y, Kostara C, Tselepis AD, Drosos AA (2006) Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment\u2014a prospective, controlled study. Arthritis Res Ther 8(3):R82","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"2114_CR30","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3109\/03009742.2012.745013","volume":"42","author":"TD Filippatos","year":"2013","unstructured":"Filippatos TD, Derdemesis CS, Voulgari PV, Tsimihodimos V, Elisaf MS, Tselepis AD, Drosos AA (2013) Effects of 12 months of treatment with disease-modifying anti-rheumatic drugs on low and high density lipoprotein subclass distribution in patients with early rheumatoid arthritis: a pilot study. Scand J Rheumatol 42(3):169\u2013175","journal-title":"Scand J Rheumatol"},{"issue":"12","key":"2114_CR31","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1002\/acr.22091","volume":"65","author":"KP Liao","year":"2013","unstructured":"Liao KP, Cai T, Gainer VS, Cagan A, Murphy SN, Liu C, Churchill S, Shaw SY, Kohane I, Solomon DH, Plenge RM, Karlson EW (2013) Lipid and lipoprotein levels and trend in rheumatoid arthritis compared to the general population. Arthritis Care Res 65(12):2046\u20132050","journal-title":"Arthritis Care Res"},{"issue":"7","key":"2114_CR32","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1136\/ard.2009.122374","volume":"69","author":"E Myasoedova","year":"2010","unstructured":"Myasoedova E, Crowson CS, Kremers HM, Fitz-Gibbon PD, Therneau TM, Gabriel SE (2010) Total cholesterol and LDL levels decrease before rheumatoid arthritis. Ann Rheum Dis 69(7):1310\u20131314","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"2114_CR33","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1002\/art.38974","volume":"67","author":"C Charles-Schoeman","year":"2015","unstructured":"Charles-Schoeman C, Fleischmann R, Davignon J, Schwartz H, Turner SM, Beysen C, Milad M, Hellerstein MK, Luo Z, Kaplan IV, Riese R, Zuckerman A, McInnes IB (2015) Potential mechanisms leading to the abnormal lipid profile in patients with rheumatoid arthritis versus healthy volunteers and reversal by tofacitinib. Arthritis Rheumatol 67(3):616\u2013625","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"2114_CR34","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1002\/art.38920","volume":"67","author":"VU Rao","year":"2015","unstructured":"Rao VU, Pavlov A, Klearman M, Musselman D, Giles JT, Bathon JM, Sattar N, Lee JS (2015) An evaluation of risk factors for major adverse cardiovascular events during tocilizumab therapy. Arthritis Rheumatol 67(2):372\u2013380","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"2114_CR35","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1002\/art.39502","volume":"68","author":"C Charles-Schoeman","year":"2016","unstructured":"Charles-Schoeman C, Wang X, Lee YY, Shahbazian A, Navarro-Mill\u00e1n I, Yang S, Chen L, Cofield SS, Moreland LW, O\u2019Dell J, Bathon JM, Paulus H, Bridges SL Jr, Curtis JR (2016) Association of triple therapy with improvement in cholesterol profiles over two-year follow up in the treatment of early aggressive rheumatoid arthritis trial. Arthritis Rheumatol 68(3):577\u2013586","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"2114_CR36","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.114.001588","volume":"4","author":"KP Liao","year":"2015","unstructured":"Liao KP, Playford MP, Frits M, Coblyn JS, Iannaccone C, Weinblatt ME, Shadick NS, Mehta NN (2015) The association between reduction in inflammation and changes in lipoprotein levels and HDL cholesterol efflux capacity in rheumatoid arthritis. J Am Heart Assoc 4(2):e001588","journal-title":"J Am Heart Assoc"},{"issue":"8","key":"2114_CR37","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1002\/art.21976","volume":"54","author":"M McMahon","year":"2006","unstructured":"McMahon M, Grossman J, FitzGerald J, Dahlin-Lee E, Wallace DJ, Thong BY, Badsha H, Kalunian K, Charles C, Navab M, Fogelman AM, Hahn BH (2006) Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 54(8):2541\u20132549","journal-title":"Arthritis Rheum"},{"issue":"9","key":"2114_CR38","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1002\/art.39675","volume":"68","author":"MJ Ormseth","year":"2016","unstructured":"Ormseth MJ, Yancey PG, Solus JF, Bridges SL Jr, Curtis JR, Linton MF, Fazio S, Davies SS, Roberts LJ 2nd, Vickers KC, KonV SCM, Investigators TETRAD (2016) Effect of drug therapy on net cholesterol efflux capacity of high-density lipoprotein-enriched serum in rheumatoid arthritis. Arthritis Rheumatol 68(9):2099\u20132105","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"2114_CR39","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/art.38894","volume":"67","author":"A Souto","year":"2015","unstructured":"Souto A, Salgado E, Maneiro JR, Mera A, Carmona L, G\u00f3mez-Reino JJ (2015) Lipid profile changes in patients with chronic inflammatory arthritis treated with biologic agents and tofacitinib in randomized clinical trials: a systematic review and meta-analysis. Arthritis Rheumatol 67(1):117\u2013127","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"2114_CR40","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1136\/ard.2004.026534","volume":"64","author":"DN Kiortsis","year":"2005","unstructured":"Kiortsis DN, Mavridis AK, Vasakos S, Nikas SN, Drosos AA (2005) Effects of infliximab treatment on insulin resistance in patients with rheumatoid arthritis and ankylosing spondylitis. Ann Rheum Dis 64(5):765\u2013766","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"2114_CR41","first-page":"921","volume":"33","author":"DN Kiortsis","year":"2006","unstructured":"Kiortsis DN, Mavridis AK, Filippatos TD, Vasakos S, Nikas SN, Drosos AA (2006) Effects of infliximab treatment on lipoprotein profile in patients with rheumatoid arthritis and ankylosing spondylitis. J Rheumatol 33(5):921\u2013923","journal-title":"J Rheumatol"},{"issue":"5","key":"2114_CR42","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1111\/j.1472-8206.2009.00717.x","volume":"23","author":"CS Derdemezis","year":"2009","unstructured":"Derdemezis CS, Filippatos TD, Voulgari PV, Tselepis AD, Drosos AA, Kiortsis DN (2009) Effects of a 6-month infliximab treatment on plasma levels of leptin and adiponectin in patients with rheumatoid arthritis. Fundam Clin Pharmacol 23(5):595\u2013600","journal-title":"Fundam Clin Pharmacol"},{"issue":"4","key":"2114_CR43","first-page":"712","volume":"29","author":"CS Derdemezis","year":"2011","unstructured":"Derdemezis CS, Voulgari PV, Drosos AA, Kiortsis DN (2011) Obesity, adipose tissue and rheumatoid arthritis: coincidence or more complex relationship? Clin Exp Rheumatol 29(4):712\u2013727","journal-title":"Clin Exp Rheumatol"},{"issue":"12","key":"2114_CR44","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.1007\/s10067-016-3422-7","volume":"35","author":"A Deodhar","year":"2016","unstructured":"Deodhar A, Bitman B, Yang Y, Collier DH (2016) The effect of etanercept on traditional metabolic risk factors for cardiovascular disease in patients with rheumatoid arthritis. Clin Rheumatol 35(12):3045\u20133052","journal-title":"Clin Rheumatol"},{"issue":"5","key":"2114_CR45","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1002\/art.39039","volume":"67","author":"N Ronda","year":"2015","unstructured":"Ronda N, Greco D, Adorni MP, Zimetti F, Favari E, Hjeltnes G, Mikkelsen K, Borghi MO, Favalli EG, Gatti R, Hollan I, Meroni PL, Bernini F (2015) Newly identified antiatherosclerotic activity of methotrexate and adalimumab: complementary effects on lipoprotein function and macrophage cholesterol metabolism. Arthritis Rheumatol 67(5):1155\u20131164","journal-title":"Arthritis Rheumatol"}],"container-title":["Heart and Vessels"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-022-02114-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00380-022-02114-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-022-02114-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T03:28:40Z","timestamp":1666150120000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00380-022-02114-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,24]]},"references-count":45,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2114"],"URL":"https:\/\/doi.org\/10.1007\/s00380-022-02114-y","relation":{},"ISSN":["0910-8327","1615-2573"],"issn-type":[{"value":"0910-8327","type":"print"},{"value":"1615-2573","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,24]]},"assertion":[{"value":"15 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All the procedures were in accordance with ethical standards and the Helsinki Declaration of 1964 and its later amendments. The study protocol was approved by the Institutional Ethics Committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}